For B2B stakeholders, the peptide therapeutics market is shaped as much by how peptides are made and sourced as by what they treat. Polaris Market Research reports that the global market was valued at USD 128.18 billion in 2025 and is projected to reach USD 315.97 billion by 2034. The report describes the market as moderately consolidated, with competition centered on innovation in synthesis technologies, therapeutic precision and expanded indications across chronic and rare diseases.

The Rise of Outsourced Peptide Manufacturing

By type of manufacturer, in-house production held the largest revenue share, at 60.0% in 2025. Large pharmaceutical companies prefer to maintain control over production in order to safeguard proprietary technologies, ensure stringent quality assurance and manage supply chain efficiency. However, outsourced peptide manufacturing is projected to witness the highest growth rate, at 10.5% during the forecast period.

Smaller biotech firms and specialty developers are increasingly relying on contract development and manufacturing organizations (CDMOs) to reduce overheads and expedite production timelines. CDMOs with expertise in solid-phase and hybrid synthesis technologies are seeing growing demand for scalable and flexible production. A January 2025 partnership between Cytovance Biologics and PolyPeptide, which combines microbial and mammalian expression capabilities with complex peptide synthesis expertise, illustrates how outsourced peptide manufacturing is evolving. High manufacturing costs, meanwhile, remain a restraint for small to mid-sized companies seeking to scale.

Liquid-Phase Peptide Synthesis and Process Efficiency

Process innovation is also reshaping production economics. In September 2024, Cambrex, through Snapdragon Chemistry, launched a new liquid-phase peptide synthesis technology that uses traditional API batch reactors and continuous flow. The approach reduces solvent usage and eliminates reliance on specialized solid-phase reactors. Growing emphasis on sustainable manufacturing, cost efficiency and scalable production is also pushing companies toward hybrid and recombinant synthesis techniques, and liquid-phase peptide synthesis is one of the technology categories tracked in the report.

Generic Peptide Therapeutics Expand Access

While innovative products held 70.0% of revenue in 2025, generic peptide therapeutics are expected to grow at the fastest CAGR of 10.3% over the forecast period. Patent expiries of key branded peptides are allowing cost-effective alternatives to enter the market. Rising demand for affordable treatment in emerging economies such as China, India, Mexico and Indonesia is pushing manufacturers to develop biosimilar and generic peptide therapeutics that expand accessibility.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/peptide-therapeutics-market 

Metabolic Disorders as a Growth Application

By application, cancer held the largest revenue share, at 18.0% in 2025, reflecting the focus on targeted therapy and immunomodulation in oncology. Yet metabolic disorders are expected to experience the fastest growth, at a CAGR of 10.0% during the forecast period. Rising prevalence of type 2 diabetes and obesity is boosting demand for peptide therapeutics that regulate insulin signaling, appetite suppression and glucose metabolism, which keeps metabolic disorders at the center of many development strategies.

Regional Dynamics and Peptide Drug Discovery

North America accounted for 42.0% of global share in 2025, and the US represented 88.0% of the regional market, driven by the rising burden of chronic diseases. Asia Pacific is projected to grow at the fastest regional CAGR of 11.0% from 2026 to 2034, supported by government focus on domestic biopharmaceutical innovation, with national health policies in India, China and South Korea fueling development through R&D funding, technology transfer initiatives and incentives for local manufacturers. China accounts for 65.0% of the Asia Pacific market.

Europe is projected to record a CAGR of 9.5%, driven by collaboration between academic institutions and biotechnology firms to advance peptide drug discovery in rare disease and oncology pipelines. In June 2025, Isogenica and Charles River collaborated to accelerate the discovery of synthetic peptides and VHH antibodies. Companies are also integrating AI-based modeling, bioinformatics and molecular design platforms to speed peptide drug discovery and reduce time-to-market.

Key Players in the Peptide Therapeutics Market

Prominent players include Amgen Inc., AstraZeneca PLC, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GSK plc (GlaxoSmithKline plc), Ipsen Pharma, Ironwood Pharmaceuticals, Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Radius Health, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Conclusion

The Peptide Therapeutics Market is anticipated to witness substantial growth as pharmaceutical companies increasingly explore targeted and effective treatment approaches. Rising demand for therapies addressing metabolic disorders, cancer, hormonal conditions, and other chronic diseases is strengthening market opportunities. Advancements in peptide synthesis, drug delivery technologies, and pharmaceutical research are improving therapeutic development capabilities. Growing investment in biotechnology and expanding clinical research activities are further supporting industry progress. Despite challenges involving manufacturing costs, stability, and drug delivery limitations, continuous innovation is enhancing the potential of peptide-based medicines. Overall, the market is expected to benefit from expanding therapeutic applications and increasing demand for advanced pharmaceutical treatments.

More Trending Latest Reports By Polaris Market Research:

Cellulose Acetate Market

Secure Logistics Market

Oceanic Bioluminescent Energy Solutions Market

Clindamycin Phosphate Injection Market

Secure Logistics Market

Muscle Stimulator Market

Power Monitoring Market

An Overview of Minimal Residual Disease Market Growth and Trends

Golf Simulator Market